DanCann Pharma A/S Publishes Q3-2024 Report: Steady Growth in Medicinal Cannabis Prescriptions Signals Promising Future for Patients November 22, 2024
CS MEDICA Welcomes the Danish Government’s Proposal to Make the Pilot Program for Prescription-Based Medicinal Cannabis Permanent November 22, 2024
DanCann Pharma A/S: The Danish Government Proposes Permanent Scheme for Prescription-Based Medicinal Cannabis for Danish Patients November 19, 2024
